BSECompany Update26 Sept 2026 · 26 Sept 2026, 08:36 pm

Re-appointment of Managing Director

Ganga Pharmaceuticals Ltd · 539680

✦ AI SummaryMgmt Change

Ganga Pharmaceuticals Ltd has announced the re-appointment of Mr. Bharat Brijmohan Sharma as Managing Director for a further period of three years effective from April 01, 2026. The re-appointment was approved by the Members of the Company at the 37th Annual General Meeting held on September 26, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Ganga Pharmaceuticals Ltd - 539680 - Announcement under Regulation 30 (LODR)-Change in Directorate

Attachments (1)

📄

79e20ffd-1bf0-4062-b23f-6b0acc89c5c7.pdf

pdf

Download →
View document text
Ganga Pharmaceuticals Limited CIN: L99999MH1989PLC053392 Regd. Office: Gangatat, Dhanvantri Marg, Gopcharpada, Virar (E), Palghar - 401305 Phone: 9834613142 |Website: www.ayurvedganga.com | Email: ayurvedganga@gmail.com September 26, 2026 BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 051 Scrip Code: 539680 Sub: Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) – Re-appointment of Managing Director Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI Listing Regulations, and based on the results declared at the 37th Annual General Meeting of the Members of the Company held on Saturday, September 26, 2026, please take note that the Members of the Company have approved the re-appointment of Mr. Bharat Brijmohan Sharma (DIN: 00077026) as Managing Director for a further period of three years effective from April 01, 2026, not liable to retire by rotation. Kindly take note that Mr. Bharat Brijmohan Sharma is not debarred from holding the office of Director by virtue of any SEBI order or order of any other such Authority. Disclosure under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is annexed herewith. The above information is also available on the website of the Company i.e., www.ayurvedganga.com. The Annual General Meeting commenced at 4:30 p.m. and concluded at 5:00 p.m. Kindly take the same on record. Thanking You, Yours faithfully, For Ganga Pharmaceuticals Limited Bharat Sharma Managing Director DIN: 00077026 Encl: As above Ganga Pharmaceuticals Limited CIN: L99999MH1989PLC053392 Regd. Office: Gangatat, Dhanvantri Marg, Gopcharpada, Virar (E), Palghar - 401305 Phone: 9834613142 |Website: www.ayurvedganga.com | Email: ayurvedganga@gmail.com Annexure Disclosure under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Sr. Particulars Details 1 Reason for change viz. appointment, Re-appointment re-appointment, resignation, removal, death or otherwise; 2 Date of appointment/cessation (as Re-appointment of Mr. Bharat Brijmohan Sharma applicable) and terms of appointment (DIN: 00077026) as Managing Director for a further period of three years effective from April 01, 2026, not liable to retire by rotation 3 Brief Profile (in case of appointment) Mr. Bharat Brijmohan Sharma possesses over 35 years of experience in Business and Pharma Industry. 4 Disclosure of relationships between Mrs. Bharat B. Sharma is spouse of Mrs. Srijna Directors Sharma, Whole-time Director of the Company.